Physician profile
Lisa E Dreyfuss
NPI 1427201607
$1,631.29
in general payments reported to CMS, 2019-2025
10 companies · $85.11 in 2025
The $85.11 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $73.06 · 2021: $188 · 2022: $236 · 2023: $261 · 2024: $17.45 · 2025: $85.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $550.42 | 2019-2025 | Grafix, Collagenase Santyl, Regranex |
| Organogenesis INC. | $466.25 | 2019-2022 | |
| Wright Medical Technology, INC. | $144.35 | 2019 | |
| Arthrosurface Incorporated | $127.95 | 2019 | |
| Liberty Surgical INC. | $125.28 | 2019 | |
| Paragon 28, INC. | $117.20 | 2019 | |
| Reprise Biomedical, INC. | $57.72 | 2024-2025 | Miro3d, Miro 3d |
| Amgen INC. | $15.79 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $13.92 | 2023 | Nuzyra |
| Hikma Pharmaceuticals USA | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dreyfuss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.